Talphera (TLPH) EBITDA Margin (QoQ) (2011 - 2023)
Talphera (TLPH) EBITDA Margin (QoQ) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 130,401.00 |
| Sep 30, 2023 | -125,943.00 |
| Jun 30, 2023 | -152,686.00 |
| Mar 31, 2022 | 40.67 Mn |
| Dec 31, 2021 | -40.82 Mn |
| Sep 30, 2021 | 175,290.00 |
| Jun 30, 2021 | -47,168.00 |
| Mar 31, 2021 | -53,647.00 |
| Dec 31, 2020 | -59,198.00 |
| Sep 30, 2020 | -42,688.00 |
| Jun 30, 2020 | 387,198.00 |
| Mar 31, 2020 | -94,949.00 |
| Dec 31, 2019 | -93,022.00 |
| Sep 30, 2019 | -80,611.00 |
| Jun 30, 2019 | 322,843.00 |
| Mar 31, 2019 | -285,760.00 |
| Dec 31, 2018 | 68,357.00 |
| Sep 30, 2018 | -159,982.00 |
| Jun 30, 2018 | 153,634.00 |
| Mar 31, 2018 | -135,579.00 |